- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AGG-523 (Aggrecanase Inhibitor)
Total 889 results
-
Ohio State UniversityRecruitingNutritional RequirementsUnited States
-
Atea Pharmaceuticals, Inc.Hoffmann-La RocheCompleted
-
AmgenCompleted
-
AllerganCompleted
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
BayerCompletedBreast NeoplasmsBelgium, Spain, Hong Kong, Taiwan, Japan, United States, Austria, Singapore, Israel, United Kingdom, Italy, Korea, Republic of, France, Poland, Switzerland, Germany, Norway
-
National Cancer Institute (NCI)CompletedNeuroblastoma | Rhabdomyosarcoma | Ewing's SarcomaUnited States
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States, United Kingdom
-
Kristina LindemannUniversity Hospital of North Norway; Haukeland University Hospital; Sorlandet... and other collaboratorsCompletedOvarian Cancer | Peritoneal CancerNorway
-
Kartos Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Cancer | Oncology | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompleted
-
AmgenCompletedAdvanced Solid Tumors
-
PrECOG, LLC.PfizerTerminatedRenal Cell CarcinomaUnited States
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLCRecruitingLung CancerUnited States
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLCRecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditionsUnited States, Finland
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
AmgenCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Switzerland, Korea, Republic of, Russian Federation, Hong Kong, Portugal, South Africa, Israel, Romania, Bulgaria, Greece, Australia, Sweden, Japan, Latvia and more
-
Boehringer IngelheimCompletedScleroderma, SystemicUnited States, Spain, United Kingdom, Belgium, Australia, Germany, Israel, China, Malaysia, Japan, Canada, Switzerland, France, Ireland, Greece, Norway, Portugal, Netherlands, Austria, Finland, Chile, Thailand, India, Argentina, Brazil, C... and more
-
Peter SiesjöSkane University Hospital; Lantmannen Medical ABRecruiting
-
Ascentage Pharma Group Inc.RecruitingMultiple Myeloma | AmyloidosisUnited States
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
Ascentage Pharma Group Inc.RecruitingBreast Cancer | Solid Tumor, AdultUnited States
-
AmgenCompletedGastrointestinal Cancer
-
University of UtahRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHematologic Diseases | Anemia, Sickle CellUnited States
-
AmgenTakedaCompletedAdvanced Gastrointestinal Stromal Tumor
-
PfizerCompletedAcute Myeloid Leukemia | Advanced MDSUnited States
-
AmgenCompletedNon Small Cell Lung CancerUnited States, Canada, Australia, Spain, Belgium, Greece
-
AmgenRecruitingAdvanced MTAP-null Solid TumorsUnited States, Canada, Taiwan, Switzerland, United Kingdom, Korea, Republic of, Germany, Austria, France, Belgium, Australia, Hong Kong, Japan
-
National Cancer Institute (NCI)SuspendedCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
AmgenCompletedCancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast CancerUnited States, Belgium, France
-
Antengene Therapeutics LimitedBristol-Myers SquibbRecruitingSolid Tumor | Hematological MalignancyAustralia
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedHIV-1 InfectionUnited States
-
GE HealthcareApproved for marketingNeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMalignant Glioma | WHO Grade 3 Glioma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Brain Neoplasm | Recurrent Childhood...United States
-
MedImmune LLCCompletedUnresectable or Metastatic Hepatocellular Carcinoma (HCC)United States
-
AmgenCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer
-
Dana-Farber Cancer Institute1 Million 4 Anna Foundation; Carson Sarcoma Foundation; Teaming up to Fight Childhood... and other collaboratorsCompleted
-
Centre Oscar LambretUnknown
-
Concert PharmaceuticalsCompletedHealthy VolunteersUnited States
-
PfizerCompletedGram-Positive Bacterial Infections | Skin and Connective Tissue Diseases
-
Consorzio OncotechPfizerRecruitingMetastatic Renal Cell CarcinomaItaly
-
Astellas Pharma Global Development, Inc.CompletedMetastatic Renal Cell CarcinomaUnited States, Canada
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
PfizerCompleted
-
TakedaCompletedGastroesophageal Reflux
-
University of PittsburghGE HealthcareCompletedStress Induced CardiomyopathyUnited States
-
Sumitomo Pharma America, Inc.CompletedHepatocellular CarcinomaUnited States
-
Grifols Therapeutics LLCCompleted